Supply of Oncotype DX Breast Recurrence Score
Estimated value
£95k
Awarded value
£95k
Awarded 29 Apr 2021
Suppliers
1
Lots
1
1 awarded
Published
23 Aug 2021
Deadline 20 Apr 2021
Description
Supply of Oncotype DX Breast Recurrence Scoring (pathology) via the National Framework Agreement for Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services
Scope
- Reference
- CF-0319600D0O000000rwimUAA1
- Total value
- £94,500 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2021 to 29 Apr 2022
- CPV classifications
- 85111800
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 20 Apr 2021, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£95k
Award date
29 Apr 2021
Contract start
30 Apr 2021
Contract end
29 Apr 2022
Awarded to